ProPhase Labs is a medical science and technology company with over-the-counter (OTC) consumer healthcare products and dietary supplements. Co. conducts its operations through two operating segments: consumer products and diagnostic services. Co.'s subsidiary, Pharmaloz Manufacturing, Inc. is a contract manufacturer and developer of a range of non-GMO, organic and natural-based cough drops and lozenges and OTC drug and dietary supplement products. The dietary supplements are developed and marketed under the TK Supplements® brand name. Co.'s subsidiary, ProPhase Diagnostics, Inc. provides a variety of medical tests, including COVID-19 and respiratory pathogen panel molecular tests. The PRPH stock yearly return is shown above.
The yearly return on the PRPH stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2017 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the PRPH annual return calculation with any dividends reinvested as applicable (on ex-dates).
|